AHFS Drug Information®

An Evidence-based Foundation for Safe and Effective Drug Therapy

AHFS Drug Information®
60th Ed.
2019 © American Society of Health-System Pharmacists
Gerald K. McEvoy, Pharm.D.
ISBN-10: 1-58528-579-X / ISBN-13: 978-1-58528-579-2
ISSN: 8756-6028
Pharmacy/Pharmacology, Drug Information, Point of Care, Public Health


Protect your patients and practice with the most comprehensive, authoritative drug information available: AHFS Drug Information®, 2018 Edition.

AHFS is the only drug information resource curated by a not-for-profit scientific organization and the only remaining original federal compendium whose authority for establishing accepted medical uses includes the broadest scope of drugs and indications under Medicaid, Medicare Part D, and more. The 2018 edition is backed by 60 years of in-depth, unbiased drug coverage—delivering authoritative data for compendia, citations, compliance and more.

Information on prescription, OTC, ophthalmic, and dermatologic drugs is evidence-based, reviewed by subject matter experts, and supported by nearly 90,000 references. AHFS Drug Information, 2018 Edition® includes therapeutic recommendations supported by primary research, extensive dosage and administration information, extensive off-label uses and related dosing options.

Updates for this edition include:

  • • Expanded and revised content throughout, featuring critical new monograph updates every year
  • • Important updated monographs and references related to revised therapeutic guidelines, including revised recommendations for treatment of fungal infections (such as Candida auris infections) and chronic hepatitis C.
  • • Newly published information on breakthrough oncology drugs approved as part of the FDA’s accelerated approval program
  • • Dedicated coverage to orphan products
  • • Interactions, adverse reactions, cautions, including ongoing revisions addressing opiate safety issues and their role in pain management.
  • • Therapeutic recommendations supported by evidence from primary research
  • • Extensive dosage and administration information.
  • • Pharmacology and pharmacokinetics
  • • Prescription, OTC, ophthalmic and dermatologic drugs
  • • Extensive off-label uses and dosing options
  • • Vaccines and other immunizing agents

Drug monographs in AHFS DI are thoroughly researched by drug information pharmacists and professional editorial and analytical staff. Authors incorporate clinical research findings, guidelines, and FDA-approved labeling into the monographs. The information also reflects the expertise of leading medical scientists, physicians, pharmacists, pharmacologists, and other clinicians, and incorporates the latest therapeutic recommendations from groups like the US Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the American Academy of Pediatrics, the American Heart Association, and many others.

This title updates: Monthly

Doody's Reviews

Doody's Core Titles (DCT)
Specialty Score: 2.8 Health Sciences - Pharmacology |2.67 Health Sciences - Pharmacy
Go to Doody's Review page

Quotes, Reviews or Testimonials

"This reference is widely used and trusted for its established record in refuting unfounded efficacy claims, its rigorous science-based editorial process, and its independence from the influence of pharmaceutical manufacturers."

-- Jennifer Colon, PharmD, MS, MBA (Temple University School of Pharmacy) - previous edition

"You cannot be a pharmacist without this book. For clinical pharmacists especially it is the standard..."

-- Miriam Klein, Pharm.D. R.Ph. (Woodhull Medical Center) - previous edition

“AHFS Drug Information is by far the most comprehensive and informative drug reference that I use. It offers much more in-depth information and post-marketing [after FDA approval] analysis on drugs.”

-- Jay S. Cohen, M.D., Associate Professor of Family and Preventive Medicine, University of California at San Diego Medical School - previous edition

“There is more in-depth information in AHFS DI, particularly pharmacology and kinetics. At times I especially need the unlabeled uses in AHFS Drug Information to answer questions. Other references don't include as many off-label uses.”

-- Paul Matuschka, Pharm.D., VA Medical Center, Louisville, KY - previous edition


This reference is intended to shape treatment decisions made by practitioners and clinicians and to influence public and private healthcare policies and decisions. It can be used as a valuable and unbiased pharmaceutical reference by clinical students and practitioners.

Table of Contents

Similar Resources